Two-year Assessment of the Efficacy and Safety of Ocrelizumab in Switching Patients from Other Disease Modifying Therapies

---

Copy For Citation

TERZİ M., BOZ C., DEMİR C. F., ÇİLİNGİR V., HELVACI E. M.

Journal of Multiple Sclerosis, 2023 (Peer-Reviewed Journal)

• Publication Type: Article / Article
• Publication Date: 2023
• Doi Number: 10.35248/2376-0389.22.9.12.475
• Journal Name: Journal of Multiple Sclerosis
• Ondokuz Mayıs University Affiliated: Yes